3.2.1.103	Rheumatic Diseases	https://pubmed.ncbi.nlm.nih.gov/9627011/	Cellular immunity to the G1 domain of cartilage proteoglycan aggrecan is enhanced in patients with rheumatoid arthritis but only after removal of keratan sulfate.	diagnostic usage	3	
3.2.1.103	Rheumatic Diseases	https://pubmed.ncbi.nlm.nih.gov/9627011/	Cellular immunity to the G1 domain of cartilage proteoglycan aggrecan is enhanced in patients with rheumatoid arthritis but only after removal of keratan sulfate.	ongoing research	4	
3.2.1.103	Rheumatic Diseases	https://pubmed.ncbi.nlm.nih.gov/9627011/	Cellular immunity to the G1 domain of cartilage proteoglycan aggrecan is enhanced in patients with rheumatoid arthritis but only after removal of keratan sulfate.	unassigned	-	
3.2.1.103	Mucopolysaccharidosis IV	https://pubmed.ncbi.nlm.nih.gov/31450640/	Development of Substrate Degradation Enzyme Therapy for Mucopolysaccharidosis IVA Murine Model.	causal interaction	4	
3.2.1.103	Mucopolysaccharidosis IV	https://pubmed.ncbi.nlm.nih.gov/31450640/	Development of Substrate Degradation Enzyme Therapy for Mucopolysaccharidosis IVA Murine Model.	diagnostic usage	3	
3.2.1.103	Mucopolysaccharidosis IV	https://pubmed.ncbi.nlm.nih.gov/31450640/	Development of Substrate Degradation Enzyme Therapy for Mucopolysaccharidosis IVA Murine Model.	therapeutic application	3	
3.2.1.103	Mucopolysaccharidosis IV	https://pubmed.ncbi.nlm.nih.gov/31450640/	Development of Substrate Degradation Enzyme Therapy for Mucopolysaccharidosis IVA Murine Model.	ongoing research	4	
3.2.1.103	Arthritis	https://pubmed.ncbi.nlm.nih.gov/8609216/	Immunity to the G1 globular domain of the cartilage proteoglycan aggrecan can induce inflammatory erosive polyarthritis and spondylitis in BALB/c mice but immunity to G1 is inhibited by covalently bound keratan sulfate in vitro and in vivo.	therapeutic application	2	
3.2.1.103	Arthritis	https://pubmed.ncbi.nlm.nih.gov/8609216/	Immunity to the G1 globular domain of the cartilage proteoglycan aggrecan can induce inflammatory erosive polyarthritis and spondylitis in BALB/c mice but immunity to G1 is inhibited by covalently bound keratan sulfate in vitro and in vivo.	unassigned	-	
3.2.1.103	Spondylitis	https://pubmed.ncbi.nlm.nih.gov/8609216/	Immunity to the G1 globular domain of the cartilage proteoglycan aggrecan can induce inflammatory erosive polyarthritis and spondylitis in BALB/c mice but immunity to G1 is inhibited by covalently bound keratan sulfate in vitro and in vivo.	therapeutic application	2